机读格式显示(MARC)

• 000 01906cam a2200397 i 4500

• 001 0000827273

• 005 20250817071700.0

• 008 240613s2025 flu b 001 0 eng

• 010 __ |a 2024026350

• 020 __ |a 9781032489520 |q hardback

• 020 __ |a 9781032496276 |q paperback

• 020 __ |z 9781003394693 |q electronic book

• 040 __ |a DNLM/DLC |b eng |e rda |c DLC |d DLC

• 042 __ |a pcc

• 050 00 |a RC270.8

• 082 00 |a 616.99/406 |2 23/eng/20241209

• 090 __ |a R730.231/X1

• 093 __ |a R730.231 |2 5

• 245 00 |a Handbook of proteases in cancer. |p Therapeutic aspects / |c edited by Sajal Chakraborti.

• 246 1_ |a Therapeutic aspects

• 250 __ |a First edition.

• 260 __ |a Boca Raton : |b CRC Press, |c 2025.

• 300 __ |a 1 volume ; |c 24 cm

• 336 __ |a text |b txt |2 rdacontent

• 337 __ |a unmediated |b n |2 rdamedia

• 338 __ |a volume |b nc |2 rdacarrier

• 504 __ |a Includes bibliographical references and index.

• 520 __ |a "This handbook provides comprehensive coverage of the application of proteases in cancer therapy. Proteases make up to two percent of the human genome and play a critical role in the tumor microenvironment. The book delves into the applications of natural, synthetic, and non-coding RNAs in cancer therapy. It highlights how effective targeting of relevant proteases can help in cancer diagnosis and treatment. It covers the systems biology and bioinformatics approach in cancer drug development"-- |c Provided by publisher.

• 650 _0 |a Tumors |x Etiology.

• 650 _0 |a Tumors |x Genetics.

• 650 12 |a Neoplasms |x drug therapy

• 650 22 |a Neoplasms |x genetics

• 650 22 |a Peptide Hydrolases |x therapeutic use

• 650 22 |a Protease Inhibitors |x therapeutic use

• 700 1_ |a Chakraborti, Sajal, |e editor.

• 776 08 |i Online version: |t Handbook of proteases in cancer. Therapeutic aspects |b First edition. |d Boca Raton : CRC Press, 2025 |z 9781003394693 |w (DLC) 2024026351